Remicade Injection, Powder, Lyophilized, For Solution
Product Images NDC 57894-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Remicade (NDC 57894-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Remicade 01)

Figure 1 (Remicade 01)
Based on the provided text, it seems to be a study or research report comparing the effectiveness of Remicade at different dosages in maintaining response in patients who had not lost such response. It appears to show that compared to placebo maintenance, Remicade at both 5 mg/kg and 10 mg/kg dosages had a statistically significant effect. The text is accompanied by a graph with different study weeks and maintenance types. The meaning of the "T" in between each line is not clear, and the significance of the number "6323" is unknown.*
FDA Label Image

Figure 2 (Remicade 02)

Figure 2 (Remicade 02)
This appears to be a graph or chart showing the percentage of patients who had not lost response in a study comparing Remicade maintenance to placebo maintenance. The x-axis represents the study week, and the y-axis represents the percentage of patients who had not lost response. There are two lines on the graph, one representing placebo maintenance and the other representing Remicade maintenance at a dose of 5 mg/kg. The graph shows that Remicade maintenance was significantly more effective in preventing loss of response compared to placebo maintenance (p=0.001).*
FDA Label Image

Figure 3 (Remicade 03)

Figure 3 (Remicade 03)
FDA Label Image

Figure 4 (Remicade 04)

Figure 4 (Remicade 04)
FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
Remicade is a medication used for injection to treat various diseases. Each vial contains 100mg and should be reconstituted by using 10 St Water for Injection, US and then diluting it with 0.9% Sodium Chloride, SP. It should not be shaken and once reconstituted, each millimeter contains 10mg of infliximab, 50mg sucrose, 0.05g polysorbate 8, 0.22mg monobasic sodium phosphate, monohydrate, and 0.51mg basic sodium phosphate, dihydrate. It does not contain any preservatives. The usual dosage should be prescribed by a doctor. The unopened vials should be stored in a cool place for up to 106 months. Unused portions should be discarded, as each vial is meant for single use only. Rxonly.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.